Study of improvement effect by switching to duraglutide or addition of empagliflozin to patients mith poor blood glucose control under multidrug combination including dipeptidyl peptidase-4inhibitor(Randomized openlabel comparative clinical study)
Not Applicable
- Conditions
- Type2 diabetes
- Registration Number
- JPRN-UMIN000027913
- Lead Sponsor
- Juntendo university Nerima hospital diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
over 65 age insulin user
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c(16 weeks later)
- Secondary Outcome Measures
Name Time Method glucose,hypoglycemia frequency,LDL-cholesterol,triglyceride,AST,ALT,BUN,creatinine,hyper tension